Northwestern Mutual Wealth Management’s Autolus Therapeutics AUTL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$238	–	3287
2023 Q2	$238	Buy	+100	New	+$237	﹤0.01%	3228
2022 Q3	–	Sell	-500	Closed	-$1K	–	3112
2022 Q2	$1K	Buy	+500	New	+$1.52K	﹤0.01%	2996
2022 Q1	–	Sell	-200	Closed	-$1K	–	3093
2021 Q4	$1K	Hold	200	–	–	﹤0.01%	2998
2021 Q3	$1K	Buy	+200	New	+$1.26K	﹤0.01%	2895

Other funds holding AUTL

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Northwestern Mutual Wealth Management's AUTL Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Autolus Therapeutics (AUTL) in Q3 2023, closing a stake of 100 shares — an estimated $238 sold.

Northwestern Mutual Wealth Management first reported a position in AUTL in Q3 2021 and held it in 4 quarters. The position peaked at $1K in Q2 2022. 71 funds tracked by Wall St. Rank hold AUTL as of Q3 2023.

Northwestern Mutual Wealth Management reported no remaining Autolus Therapeutics position as of Q3 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 100 Autolus Therapeutics shares in Q3 2023, an estimated $238.
Northwestern Mutual Wealth Management first reported a position in Autolus Therapeutics in Q3 2021 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Autolus Therapeutics position peaked at $1K in Q2 2022.
71 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.